About Biocatalysis
Biocatalysis is a company based in Germany founded in 2002 was acquired by Cambrex in March 2010.. Biocatalysis operates in a competitive market with competitors including Almac Group, Seqens, Asymchem, Aurobindo Pharma and Aptuit, among others.
- Headquarter Germany
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biocatalysis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biocatalysis
Biocatalysis has secured backing from 1 investor. Prominent investors backing the company include Cambrex. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CDMO of complex small molecule APIs, including highly potent APIs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biocatalysis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biocatalysis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biocatalysis Comparisons
Competitors of Biocatalysis
Biocatalysis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Seqens, Asymchem, Aurobindo Pharma and Aptuit, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
Contract manufacturing services for small molecules and peptides are provided.
|
|
| domain | founded_year | HQ Location |
APIs and peptides are developed and manufactured by Asymchem.
|
|
| domain | founded_year | HQ Location |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| domain | founded_year | HQ Location |
Contract research and development services for small molecules are offered.
|
|
| domain | founded_year | HQ Location |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Biocatalysis
When was Biocatalysis founded?
Biocatalysis was founded in 2002.
Where is Biocatalysis located?
Biocatalysis is headquartered in Germany.
Who is the current CEO of Biocatalysis?
Thomas Loewald is the current CEO of Biocatalysis.
What does Biocatalysis do?
Biocatalysis was founded in 2002 in Germany and operates as a contract development and manufacturing organization. Small molecule drugs and peptides are produced through biocatalytic processes for pharmaceutical clients. Services include process development, scale-up, and quality-controlled production. The company is based in Germany, serving the biotech and pharmaceutical sectors with specialized manufacturing capabilities.
Who are the top competitors of Biocatalysis?
Biocatalysis's top competitors include Concord Biotech, Almac Group and Indoco Remedies.
Who are Biocatalysis's investors?
Biocatalysis has 1 investor. Key investors include Cambrex.